Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Marie-Odile
Marie-Odile Galcera-Contour, Bondoufle FR
| Patent application number | Description | Published |
|---|---|---|
| 20090082345 | BENZOTHIAZOLE- AND BENZOOXAZOLE-4,7-DIONE, DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATE INHIBITORS - The invention concerns the use as cdc25 phosphatase inhibitors, in particular cdc25-C phosphatase, and CD45 phosphatase, of compounds of general formula (I), wherein: W represents O or S. In accordance with the invention, the compounds of general formula (I) can in particular be used for preparing a medicine for cancer treatment. | 03-26-2009 |
| 20090131428 | BENZOOXAZOLE-4,7-DIONE, DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATE INHIBITORS - The invention concerns the use as cdc25 phosphatase inhibitors, in particular cdc25-C phosphatase, and CD45 phosphatase, of compounds of general formula (I), wherein: W represents O or S. In accordance with the invention, the compounds of general formula (I) can in particular be used for preparing a medicine for cancer treatment. | 05-21-2009 |
| 20090275624 | INHIBITORS OF CDC PHOSPHATASES - A subject of the present invention is novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer. | 11-05-2009 |
| 20100317658 | 4,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic Uses - A subject of the present invention is 4,7-dioxobenzothiazole-2-carboxamide derivatives, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer. | 12-16-2010 |
Marie-Odile Gourdin, Cucuron FR
| Patent application number | Description | Published |
|---|---|---|
| 20110190671 | Massage and/or Care Device Using a Jet of Droplets - A device for providing massage and/or care by means of a jet of drops of liquid, the device comprising a liquid feed circuit ( | 08-04-2011 |
Marie-Odile Habert, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110046451 | METHOD AND AUTOMATED SYSTEM FOR ASSISTING IN THE PROGNOSIS OF ALZHEIMER'S DISEASE, AND METHOD FOR TRAINING SUCH A SYSTEM - A method and automated system for assisting in the prognosis of the progress and for assisting in the diagnosis of Alzheimer's disease in patients suffering from mild cognitive impairment (MCI). Also provided is a method for training such a system related to identifying discriminant regions of the brain and using these regions to fine tune the assistance method, based on new known cases. | 02-24-2011 |
Marie-Odile Jauberteau, Limoges FR
| Patent application number | Description | Published |
|---|---|---|
| 20110178023 | Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands - The invention relates to a polypeptide derived from the TSR (thrombospondin type 1 units) of SCO-Spondin for inhibiting or preventing the apoptosis mediated by the cell death receptor ligands, such as TRAIL or FasL. The polypeptide of the invention comprises a sequence -W-S-A1-C-S-A2-C-G- wherein A1 and A2 are amino acid sequences comprising 1 to 5 amino acids. More particularly, the invention relates to said polypeptide for inhibiting or preventing the apoptosis associated with a disease selected from the group consisting of neurodegenerative disorders, cerebral ischemia, neuronal traumas, neuronal inflammatory diseases, and viral neurodegenerations. | 07-21-2011 |
Marie-Odile Lonchampt, Chevilly-Larue FR
| Patent application number | Description | Published |
|---|---|---|
| 20090270341 | PRODUCT COMPRISING A TRANSDUCTION INHIBITOR OF HETEROTRIMERIC G PROTEIN SIGNALS COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER - A composition for treating cancer comprising an anti-tumorally effective amount of a product comprising at least one transduction inhibitor of heterotrimeric G protein signals and at least one other anti-cancer agent selected from the group consisting of prenyltransferase inhibitors, taxol and its analogues, gemcitabine and camptothecin and its analogues, administered simultaneously, separately or spread over a period of time and a pharmaceutical carrier. | 10-29-2009 |
Marie-Odile Ruault, Saint Jean De Beauregard FR
| Patent application number | Description | Published |
|---|---|---|
| 20080237874 | Method of Producing a Silicon Oxide-Based Material with a Low Dielectric Constant - A method for manufacturing a material with a low dielectric constant, comprising a step of forming cavities in silicon dioxide by implantation of a rare gas different from helium and from neon at an implantation dose greater than 10 | 10-02-2008 |
Marie-Odile Sadoulet, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20090285823 | GLYCOPEPTIDES DERIVED FROM PANCREATIC STRUCTURES, ANTIBODIES AND APPLICATIONS THEREOF IN DIAGNOSTICS AND THERAPEUTICS - Glycopeptide comprising 1 to 40 repeated C-terminal polypeptides, with 11 amino acids, of BSDL or FAPP, whereby said polypeptides are glycosylated and bear glycosylated epitopes giving rise to a specific immunological reaction with induced antibodies in a patient suffering from type 1 diabetes and/or purified from biological fluids of human or animal origin or recombinant and produced by expression in a standard host cell comprising an enzymatic material necessary for priming a glycosylation, said host cell being genetically modified such as to comprise a gene coding for said polypeptides and a gene coding for one or more enzymes selected from among glycosyltransferases, anti-glycopeptide antibodies and the applications thereof in therapeutics and diagnostics. | 11-19-2009 |
Marie-Odile Stalin, Lille FR
| Patent application number | Description | Published |
|---|---|---|
| 20110178288 | PROCESS FOR THE PRODUCTION OF MALTODEXTRINS AND MALTODEXTRINS - There is disclosed a process for preparing liquid maltodextrin having a D.E. of about 5 to less than about 20. Also disclosed are liquid maltodextrins having a D.E. of about 9 to about 15. | 07-21-2011 |
Marie-Odile Vallez, Montreuil FR
| Patent application number | Description | Published |
|---|---|---|
| 20090075976 | Association between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor - The present invention relates to the association of an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor (ACEI), and also to pharmaceutical compositions containing them, and to methods of treating vascular complications associated with diabetes, with atherothrombotic diseases, with hyperlipidaemia, with hypertension, with chronic venous diseases, with inflammation, with metabolic syndrome associated with obesity, or with cancer, with such association. | 03-19-2009 |
| 20090131668 | 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds - Compound of formula (I): | 05-21-2009 |
| 20100330064 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them - Compounds of formula (I): | 12-30-2010 |